performed in CD families by nonparametric linkage analysis [5] . In 2001, two studies identified the NOD2 gene as the first CD susceptibility gene [6, 7] with rare allelic variants presenting high penetrance (odd ratio,~3.99). In the past 5 years, genome-wide association studies (GWAS), looking at frequencies of single nucleotide polymorphisms (SNPs) between IBD patients and healthy controls, have increased exponentially the number of IBD susceptibility loci (for review [8] ). A recent meta-analysis based on GWAS results compiled 71 risk loci in Crohn's disease and 47 in ulcerative colitis, with 28 exhibiting shared associations [9] . Of note, NOD2/CARD15 gene association with CD has been well replicated by GWAS. Most of other genes identified display risk variants commonly found in the general population and confer a modestly increased risk of developing IBD (odd ratio,~1.08-2.5) [9] . Altogether, GWAS results explain barely 23 and 16 % of the overall variance in CD and UC risks, respectively. Some genetic factors could explain in part this missing heritability, such as the existence of rare susceptibility variants, not detected by GWAS, that are designed to characterize variants of >1 % frequency. Hence, recent studies using deep sequencing have allowed identification of new additional risk variants in unpreviously characterized susceptibility genes, such as the endoplasmic reticulum (ER) stress-related XPB1 gene [10] or in susceptibility genes identified by GWAS, with, for example, the identification of five rare additional risk variants in the prototypical CD susceptibility gene NOD2 [11] . Missing heritability in CD cannot be explained by genetic factors alone. Nevertheless, it is striking that most susceptibility genes identified belong to a restricted number of pathways involved in intestinal barrier function, autophagy ( Fig. 1) , microbial defense, innate immune regulation, lymphocyte differentiation, reactive oxygen species (ROS) generation,
CD hallmarks
Sensors and integrators Autophagy core machinery A wide range of cellular stresses occurring during IBD onset (left red side of the panel) are integrated by molecular sensors and associated signaling pathways (gray arrow) and could allow regulation of the autophagy process (right green side) in various cell types (e.g., intestinal epithelial cells, neutrophils, macrophages dendritic cells, and other cell types closely associated with the gut). Autophagy (macroautophagy) induction is under the control of two major regulatory protein complexes: 1 mTORC1 complex and the Beclin1/class III PI3K Vps34 complex. 2 Autophagy initiation is characterized by the formation of an isolation membrane (phagophore) that could derive from different membrane sources (plasma membrane, ER, mitochondria or Golgi complex), depending probably on the cell type or stresses. 3 Elongation and completion of this membrane, mediated by two ubiquitin-like conjugation systems, the Atg12-Atg5-Atg16L1 and the LC3-II complexes, 4 lead to the formation of a LC3-II positive double-or multi-membrane vacuole, called autophagosome. 5 Fusion of the autophagosome with the lysosomes forms an autolysosome, allowing the lysis of the inner membrane and degradation of the intraluminal contents. Proteins encoded by CD-susceptibility genes are in red or ER stress. It is widely admitted that risk variants alter the regulation or efficiency of these key molecular pathways following environmental stresses, in an acute or chronic manner, leading to chronic gut disorders. Interestingly, these pathways are mostly engaged in host response against microbes and intracellular bacteria handling, indicating a possible involvement of pathogens in CD etiology.
Microbial trigger in CD etiology
Since the first description of CD and UC, it was thought that commensal microbiota or infectious agents are involved in the pathogenesis and clinical course of IBD. Indeed, the two major sites of lesions in CD, the terminal ileum and colon, overlap with gut regions of greater microorganism density. In addition, reducing the level of mucosal associated bacteria, either by fecal stream diversion [12] or broad-spectrum antibiotics (such as metronidazole or ciprofloxacin) (for review [13] ), induces a clinical improvement in a subset of active CD patients. Metagenomic analyses have revealed a breakdown in the balance between "protective" and "harmful" intestinal bacteria in the gut of CD patients, with a decrease in the abundance of the Firmicutes (Clostridium and Bacillus species Gram-positive bacteria), and an increase in Proteobacteria (Gram-negative bacteria, including Escherichia spp.) [14, 15] . Aside dysbiosis, some specific microorganisms have been suspected to act as an infectious trigger in CD etiology, including Mycobacterium avium subsp. paratuberculosis, adherent-invasive Escherichia coli (AIEC), and yeasts [16] . Interestingly, the increase in Escherichia spp., found by metagenomic analyses, has also been reported by several independent groups using classical culture techniques or molecular biology based-approaches [17] [18] [19] [20] [21] [22] . This abnormal colonization by E. coli strains is especially observed on the ileal mucosa of CD patients. These strains, termed AIEC, display pathogenic features: They are able to adhere to and to invade/replicate within intestinal epithelial cells and also to survive and to replicate within macrophages, thereby inducing the secretion of large amounts of tumor necrosis factor alpha. They form biofilm on the surface of the ileal mucosa owing to an abnormally increased expression of CEACAM6 receptor [23] , induce epithelial injury, and significantly increase erosive lesions and mucosal inflammation [24] . The exact origin of the dysbiosis, and the associated E. coli abnormal colonization, in CD patient remains to be elucidated. Various explanations have been suggested, including the hygiene hypothesis linked to frequent use of antibiotics or microbicidal substances, a breakdown of microbiota homeostasis following acute gastroenteritis by pathogens such as Salmonella spp. or Campylobacter spp. [25] , or the impact of dietary compounds (refined sugar for example) used in the food of developed countries that could favor the growth of certain bacterial species [26] . Another attractive hypothesis is that the genetic polymorphisms observed in CD, in association with other environmental factors, could lead, in some individuals, to an inappropriate immune response, creating niches for abnormal, long-lasting colonization by detrimental bacteria, such as AIEC. This latter hypothesis will be examined more closely in the next part of this review, with a specific focus on autophagy-related gene polymorphisms and their impact on intracellular bacteria handling and associated proinflammatory response in CD etiology.
CD-associated risk polymorphisms in autophagy-related genes
Autophagy is a lysosomal bulk degradative process, evolutionarily conserved from yeast to mammals, whereby eukaryotes re-cycle damaged or excess organelles and long-lived proteins [27] . Three forms of autophagy have been described in higher eukaryotes, named macroautophagy, microautophagy, and chaperone-mediated autophagy. Macroautophagy (referred to simply as "autophagy" below) involves the formation of intermediate membrane-surrounded structures, so-called autophagosomes, which engulf the substrates and deliver them to lysosomes for degradation. Different subtypes of selective autophagy have been described according to the nature of the substrate targeted: hence, aggrephagy refers to degradation of aggregated proteins [28] , pexophagy to peroxisome degradation [29] , mitophagy to mitochondria degradation [30] , reticulophagy to ER degradation [31] , and xenophagy, which could be particularly important in the etiology of CD, to the degradation of intracellular microorganisms [32] . The crucial role of autophagy in cellular homeostasis has been convincingly demonstrated by the embryonic lethality observed in the vast majority of mice knocked out for autophagy genes, and so, it seems puzzling that a general autophagy defect could be associated with CD. CD-risk variants in autophagy-related genes occur with a relatively high prevalence in healthy people. This definitively excludes a severe phenotype due to a general defect in autophagy. Thus, risk variants in autophagy-related genes would be expected to have only subtle effects on autophagy particularly in response to particular stress. Interestingly, the regulatory pathways of autophagy are able to integrate a wide range of stress signals that are part of CD physiopathology ( Fig. 1) , such as the persistence of intracellular bacteria, nuclear factor kappa B (NF-κB) activation, proinflammatory cytokines, hypoxia, ER stress, ROS production, and the associated genotoxic stress [33] . This suggests that autophagy is particularly challenged and active before and during CD onset, impacting on the age of onset, severity, and relapse of the disease. Genetic studies have highlighted the potential role of the autophagy pathway in CD onset with the identification of risk polymorphisms in various autophagy-related genes (Table 1 and Fig. 1 ), including genes encoding core machinery proteins of this process (ULK1, ATG4, and ATG16L1), regulatory proteins [immunity-related GTPase family M (IRGM) and leucine-rich repeat kinase 2 (LRRK2)] and pattern-recognition receptors involved in autophagy induction [nucleotide-binding oligomerization domain-containing protein 2 (NOD2) and Toll-like receptor 4 (TLR4)] [6, 7, [34] [35] [36] [37] [38] [39] [40] [41] . These risk polymorphisms account for coding or noncoding changes in the sequence of the mature related proteins. In addition to genetic studies, functional studies to determine the causality of these risk variants in CD are required. Various studies have already explored the potential impact of CD risk variants in autophagy-related genes, in vitro and in vivo, on the autophagic process. In vitro experiments have demonstrated that CD-risk polymorphisms in ATG16L1 and NOD2 affect intracellular bacteria clearance by xenophagy [42] [43] [44] [45] . It was exciting to see for the first time that polymorphisms in the first most reliable CD-risk gene, NOD2, lead to a similar xenophagic defect phenotype as polymorphism in the ATG16L1 gene [45, 46] . In addition, defects in the autophagy process result in an exacerbated pro-inflammatory response upon TLR or NOD ligands treatment or during infection by invasive bacteria [47] [48] [49] . However, as explained above, these polymorphisms in autophagy-related genes probably induce fine qualitative and/or quantitative changes in the corresponding proteins, requiring an exogenous trigger to generate a deleterious phenotype in a subset of patients. A first striking example of this notion was given by Cadwell and colleagues, who demonstrated that chronic infection by a specific strain of murine norovirus (MNV CR6) is able to sensitize mice to DSS colitis, but only those that have genetic susceptibility at the ATG16L1 locus (ATG16L1 hypomorphic mice) [50] . MNV seems to act by altering granule packaging in Paneth cells specifically in ATG16L1 hypomorphic mice. Interestingly, similar Paneth cell abnormalities are observed in CD patients homozygous for the risk allele of ATG16L1 but not in control patients, suggesting a possible similar mechanism in CD etiology [51] .
In a recent paper, we provided a second illustration of the role of a CD-risk variant revealed by an exogenous trigger, a silent polymorphism in the autophagy-related IRGM gene that leads to deleterious effects upon microRNA regulation [52] .
Noisy role of the noncoding SNP in IRGM revealed by the absence of regulation by microRNA IRGM belongs to the immunity-related GTPases (IRGs) family and contributes to a cell-autonomous resistance system essential for the control of intracellular pathogens [53] . It is a fast-evolving family with a number, type, and diversity of genes present in this family that differ greatly between closely related species. As a result, the mouse IRG family consists of at least 21 genes, which are interferon controlled, whereas only a single syntenic truncated IRGM copy is present in human [54] . Human IRGM shares similarity with mouse Irgm1; however, it is truncated at the C-terminus and thus harbors a defective GTPase domain. In addition, human IRGM promoter is not responsive to interferon-γ (IFN-γ); its expression is under the control of the human endogenous retrovirus element, ERV9 [55] .
Irgm1
−/− mice show increased susceptibility to Listeria monocytogenes and Toxoplasma gondii [56] , probably due to a defect in xenophagy induction and phagosome/autophagosome maturation [57] [58] [59] . Disparities in IRG protein conservation and numbers makes it difficult to extrapolate the results obtained from mouse models to human functions of IRGM protein; however, its key role in autophagy regulation seems to be conserved. Human IRGM gene products have been shown to induce xenophagy, allowing clearance of various intracellular bacteria such as Mycobacterium tuberculosis, Salmonella typhimurium, or CD-associated E. coli (AIEC) [44, 47, 59, 60] . The expression level of IRGM protein correlates with the intracellular bacteria uptake by xenophagy in epithelial cells and macrophages [34, 52, 59] , suggesting that IRGM acts as a rheostat to fine tune the autophagy process. Hence, CD-risk polymorphisms found in the IRGM gene could lead to differences in expression level and lead to functional alterations in the ability of cells to initiate and sustain autophagy against intracellular-persistent bacteria.
A synonymous variant within the IRGM coding region (rs10065172, CTG>TTG, leucine) was initially linked to CD [38] , and this silent polymorphism was found to be in perfect linkage disequilibrium (r 2 01.0) with a 20-kb deletion upstream of IRGM [60] (Fig. 2) . Hence, the CD-risk However, the colon carcinoma HCT116 cells express exclusively the CD-risk haplotype (T) [60] , indicating that the 20-kb deletion does not impair in a reliable manner the expression of the IRGM mRNA. An alternative hypothesis is that the synonymous exonic (CTG>TTG, leucine) variant might affect protein expression. In this regard, we have demonstrated that the silent polymorphism alters the recognition of the IRGM mRNA by a family of microRNA (miR), called miR-196 (Fig. 3) . The polymorphism is located within the seed sequence, a sequence essential for the binding of the microRNA (miRNA) to the target mRNA. In most cases, a single base mismatch between mRNA and the miRNA seed region is sufficient to alter recognition by the miR, thereby preventing translation repression or mRNA degradation [61] . We showed both in silico and in vitro that this synonymous variation alters the binding site for the miR-196 family [52, 62] . Ex vivo, miR-196 is overexpressed in the intestinal epithelia of CD patients, in both inflamed and noninflamed areas [52, 63] , where it downregulates the IRGM protective variant (IRGM C ) but not the CD-risk variant (IRGM T ). These results highlight the fact that a differential regulation of IRGM protein level exists between patients bearing the protective allele or risk allele C313T in IRGM gene, according to the expression of the miR196 family. This uncontrolled IRGM protein level could have a profound impact on the ability of the cell to initiate and sustain xenophagy against intracellular pathogens (Fig. 4) . This notion has also been discussed in studies of the effects of decreased IRGM protein level in human epithelial cells or macrophages either using specific small interfering RNA against IRGM [44, 47, 59, 60] or transfecting increased amounts of miR-196 [52] . Unexpectedly, an increase in IRGM protein level leads to a loss of control in intracellular replication of CD-associated bacteria within epithelial cells, as observed with decreased IRGM levels. Despite the fact that an increase in the level of IRGM protein leads to an apparent higher intracellular bacteria uptake by xenophagy, this affects also the process of bacterial clearance due to the decrease in lysosomal fusion. Hence, a reduced level of IRGM is needed to control the entry flow of bacteria through the xenophagic degradation system to ensure efficient bacterial killing. This property could be particularly crucial in the etiology of CD, in which intestinal epithelial cells are highly challenged by bacteria presenting pathogenic features and the ability to invade host cells, such as AIEC [18] . Another possible deleterious effect of uncontrolled IRGM expression has been reported by Singh and colleagues [64] who observed that overexpression of some IRGM isoforms, i.e., IRGMa, IRGMc, and IRGMd, is detrimental to the cell by causing inflammatory cell death, and releasing large amounts of a major proinflammatory damage-associated molecular pattern protein. Such a molecular mechanism could also fuel inflammation before and during IBD onset, and the death of enterocytes could provide a breach for intestinal microorganisms to the subepithelial compartment. A recent study reported that in some virus infections involving Measle virus, hepatitis C virus, or human immunodeficiency virus-1, which have been suspected to play a role in IBD, the virus replication is favored by increased IRGM expression in host cells [65] . 
Conclusions and perspectives
Analyses of the genes implicated in CD revealed several biological pathways that seem to be crucial in IBD onset. Among them autophagy is a bona fide candidate pathway with several autophagy-related genes associated with CD (ATG16L1, IRGM, NOD2, ULK1, LRRK2, and TLR4). The autophagy regulatory network integrates various stresses involved in CD (persistence of intracellular bacteria, NF-κB activation, hypoxia, ER stress, ROS production, and the associated genotoxic stress). In vitro experiments have demonstrated unequivocally that modified protein levels or expression of risk variants of ATG16L1, IRGM, and NOD2 impaired the control of persistent intracellular bacteria suspected to be involved in the onset of CD. However, since autophagy is a crucial homeostatic process in all cell types and the frequency of CD-risk allele in autophagy-related genes is relatively high in the general population, the impact of risk polymorphisms in autophagy-related genes may require additional triggers to reveal a deleterious phenotype and to lead to a symptomatic chronic inflammation. This was illustrated by the report of virus-plus-susceptibility gene interaction in the case of ATG16L1 [50] and by our work on IRGM silent polymorphism responsible for a loss of regulation by a miR family overexpressed in the intestinal epithelium of CD patients [52] . Regulation by miRNAs therefore represents an ideal thermostat to rapidly adapt the level of IRGM to various stresses and to maintain tissue homeostasis. It remains to be determined whether miR-196 overexpression imnvolved in the loss of IRGM protein level control is a primary or a secondary event (subsequent to the inflammatory state) in CD onset. Higher expression of miR-196 in noninflammatory areas of CD patient biopsies, compared to those of controls [52, 63] , argues for an early role in IBD onset in our model by combining expression levels of IRGM allele, miR-196 expression, and control of intracellular bacterial load. The growing number of genetic and non genetic elements contributing to the complex etiology of CD raises the question of a multihit model for IBD, in which multiple events or triggers, in an ordered sequence, lead to IBD onset. Further investigations are needed to explore the functional associations between disease susceptibility, genetic variation, and many other parameters such as microbiota composition, patient history (previous viral or bacterial infection), and dietary habits. It is important to consider the biological T presents no phenotypical differences compared to the protective variant (IRGM C ), with a normal autophagic process in both genotypes. In the early phase of CD onset, an increase in miR-196 expression leads to a difference in IRGM protein level regulation between risk and protective IRGM variant. In patients bearing the risk allele, IRGM level is not controlled and could lead to inefficient xenophagic process unable to clear intracellular bacteria. IRGM-controlled level acts as a fine tune of the xenophagic process by limiting the deleterious effects of a bacterial overload in autophagic compartments. Finally, a strong overexpression of miR-196, as observed in inflamed mucosa of CD patients, which occurs late in CD onset, could be detrimental for both patient genotypes. In patient expressing IRGM C variant, strong expression of miR-196 could dramatically downregulate IRGM protein level, thereby shutting down the autophagy machinery. This model emphasizes the importance of a fine control of IRGM expression in intestinal epithelial cells to ensure cell homeostasis and efficient bacterial clearing pathways highlighted by GWAS and deep sequencing analysis, since this could link various events and potentially offer novel therapeutic targets for existing drugs or new drug design. For example, in the case of autophagy, two reports have shown marked and sustained improvement in CD symptoms in patients with refractory CD treated with rapamycin analogues (Everolimus and Sirolimus) [66, 67] , remissions that are perhaps beyond the immunosuppressive properties of these drugs but more likely linked to their ability to induce autophagy. Studies have already identified other classes of molecules, already FDA approved, that modulate the autophagic process [68, 69] . Interestingly, some of these compounds displayed great efficiency in the treatment of Huntington's disease, a neurodegenerative disease involving a defect in the autophagic process [70] . In CD, according to the patient genotype for autophagy-related genes, the use of well-tolerated pharmacological autophagic inducers could achieve a double benefit by concomitantly restraining the load of intracellular CD-associated bacteria and slowing down inflammatory response.
